Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1990 4
1991 7
1992 7
1993 5
1994 10
1995 6
1996 11
1997 6
1998 7
1999 7
2000 7
2001 15
2002 10
2003 15
2004 15
2005 21
2006 14
2007 20
2008 21
2009 27
2010 24
2011 18
2012 19
2013 15
2014 21
2015 11
2016 19
2017 18
2018 24
2019 15
2020 31
2021 35
2022 27
2023 23
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

490 results

Results by year

Filters applied: . Clear all
Page 1
Enhanced recovery after surgery (ERAS) in gynecology oncology.
Bogani G, Sarpietro G, Ferrandina G, Gallotta V, DI Donato V, Ditto A, Pinelli C, Casarin J, Ghezzi F, Scambia G, Raspagliesi F. Bogani G, et al. Among authors: ferrandina g. Eur J Surg Oncol. 2021 May;47(5):952-959. doi: 10.1016/j.ejso.2020.10.030. Epub 2020 Oct 28. Eur J Surg Oncol. 2021. PMID: 33139130 Review.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, Bologna A, Weber B, Raspagliesi F, Panici PB, Cormio G, Sorio R, Cavazzini MG, Ferrandina G, Breda E, Murgia V, Sacco C, Cinieri S, Salutari V, Ricci C, Pisano C, Greggi S, Lauria R, Lorusso D, Marchetti C, Selvaggi L, Signoriello S, Piccirillo MC, Di Maio M, Perrone F; Multicentre Italian Trials in Ovarian cancer (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO); Mario Negri Gynecologic Oncology (MaNGO); European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG) Investigators. Pignata S, et al. Among authors: ferrandina g. Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28. Lancet Oncol. 2014. PMID: 24582486 Clinical Trial.
New medical approaches in advanced ovarian cancer.
Corrado G, Palluzzi E, Bottoni C, Pietragalla A, Salutari V, Ghizzoni V, Distefano M, Scambia G, Ferrandina G. Corrado G, et al. Among authors: ferrandina g. Minerva Med. 2019 Aug;110(4):367-384. doi: 10.23736/S0026-4806.19.06139-1. Epub 2019 May 22. Minerva Med. 2019. PMID: 31124637 Review.
Optimizing treatment in recurrent epithelial ovarian cancer.
Corrado G, Salutari V, Palluzzi E, Distefano MG, Scambia G, Ferrandina G. Corrado G, et al. Among authors: ferrandina g. Expert Rev Anticancer Ther. 2017 Dec;17(12):1147-1158. doi: 10.1080/14737140.2017.1398088. Epub 2017 Nov 6. Expert Rev Anticancer Ther. 2017. PMID: 29086618 Review.
Novel targets for VEGF-independent anti-angiogenic drugs.
Petrillo M, Scambia G, Ferrandina G. Petrillo M, et al. Among authors: ferrandina g. Expert Opin Investig Drugs. 2012 Apr;21(4):451-72. doi: 10.1517/13543784.2012.661715. Epub 2012 Feb 20. Expert Opin Investig Drugs. 2012. PMID: 22339615 Review.
Assessing the role of minimally invasive radical hysterectomy for early-stage cervical cancer.
Bogani G, Di Donato V, Muzii L, Casarin J, Ghezzi F, Malzoni M, Greggi S, Landoni F, Bazzurini L, Zanagnolo V, Multinu F, Angioli R, Plotti F, Caruso G, Fischetti M, Ferrandina G, Palaia I, Benedetti Panici P, Scambia G, Raspagliesi F. Bogani G, et al. Among authors: ferrandina g. Eur J Obstet Gynecol Reprod Biol. 2022 Aug;275:64-69. doi: 10.1016/j.ejogrb.2022.06.004. Epub 2022 Jun 8. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35753229 Review.
Targeting CD133 antigen in cancer.
Ferrandina G, Petrillo M, Bonanno G, Scambia G. Ferrandina G, et al. Expert Opin Ther Targets. 2009 Jul;13(7):823-37. doi: 10.1517/14728220903005616. Expert Opin Ther Targets. 2009. PMID: 19530986 Review.
Radiomics systematic review in cervical cancer: gynecological oncologists' perspective.
Bizzarri N, Russo L, Dolciami M, Zormpas-Petridis K, Boldrini L, Querleu D, Ferrandina G, Pedone Anchora L, Gui B, Sala E, Scambia G. Bizzarri N, et al. Among authors: ferrandina g. Int J Gynecol Cancer. 2023 Oct 2;33(10):1522-1541. doi: 10.1136/ijgc-2023-004589. Int J Gynecol Cancer. 2023. PMID: 37714669 Review.
490 results